Adjuvanted vaccine strategies and live vector approaches for the prevention of AIDS.
Voss
G
G
Research and Development, Smithkline Beecham Biologicals, Rixensart, Belgium.
Villinger
F
F
D016915:AIDS Vaccines / Q000276:immunology*; D000276:Adjuvants, Immunologic; D000818:Animals; D015195:Drug Design; D005822:Genetic Vectors; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology; D006801:Humans; D051379:Mice; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology; D014780:Viruses / Q000235:genetics*
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D011994:Recombinant Proteins